Modulation of intestinal corticotropin-releasing hormone signaling by the herbal preparation STW 5-II: possible mechanisms for irritable bowel syndrome management
Corticotropin-releasing factor (CRF) mediates stress responses and alters the gut-brain axis, contributing to the pathogenesis of irritable bowel syndrome (IBS), which is recognized by abdominal pain accompanied by bowel habit disturbance. STW 5-II, a mixture of six herbal extracts, is clinically ef...
Saved in:
| Main Authors: | , , , , |
|---|---|
| Format: | Article (Journal) |
| Language: | English |
| Published: |
8 September 2022
|
| In: |
Pharmaceuticals
Year: 2022, Volume: 15, Issue: 9, Pages: 1-17 |
| ISSN: | 1424-8247 |
| DOI: | 10.3390/ph15091121 |
| Online Access: | Resolving-System, lizenzpflichtig, Volltext: https://doi.org/10.3390/ph15091121 Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/1424-8247/15/9/1121 |
| Author Notes: | Mohamed Elbadawi, Ramy M. Ammar, Sabine Rabini, Sabine M. Klauck and Thomas Efferth |
| Summary: | Corticotropin-releasing factor (CRF) mediates stress responses and alters the gut-brain axis, contributing to the pathogenesis of irritable bowel syndrome (IBS), which is recognized by abdominal pain accompanied by bowel habit disturbance. STW 5-II, a mixture of six herbal extracts, is clinically effective in functional dyspepsia and IBS. Here we aimed to establish an organoid-based stress-induced IBS-like model to investigate the mechanisms of action of STW 5-II. |
|---|---|
| Item Description: | Gesehen am 29.11.2022 |
| Physical Description: | Online Resource |
| ISSN: | 1424-8247 |
| DOI: | 10.3390/ph15091121 |